Abstract

Get full access to this article
View all access options for this article.
References
1.
Johnstone
A
. Gout — the disease and non-drug treatment . Hosp Pharm
2005 ; 12 :391 –3
2.
Wortmann
RL
. Disorders of purine and pyrimidine metabolism . Harrison's Online . Available: www.accessmedicine.com (accessed April 21, 2006)
3.
Hawkins
DW
Rahn
DW
. Gout and hyperuricemia , In:
DiPiro
JT
Talbert
RL
Yee
GC
. (eds). Pharmacotherapy — a pathophysiologic approach . 6th ed.
Toronto : McGraw-Hill ; 2005
4.
Rose
BD
. Diuretic-induced hyperuricemia and gout . In: UpToDate . Available: www.uptodate.com (accessed March 13, 2006)
5.
Quiceno
GA
Cush
JJ
. Iatrogenic rheumatic syndromes in the elderly . Clin Geriatr Med
2005 ; 21 (3 ): 577 –88
6.
Scott
JT
. Drug-induced gout . Bailliere's Clinical Rheumatology
1991 ; 5 (1 ): 39 –60
7.Gout . In: Bandolier. Available: www.jr2.ox.ac.uk/bandolier/booth/booths/gout.html (accessed May 13, 2006 )
8.
Koda-Kimble
MA
Young
LY
Kradjan
WA
. Applied therapeutics: the clinical use of drugs . 8th ed.
Baltimore : Lippincott Williams and Wilkins ; 2005
9.
Manolis
AJ
Grossman
E
Jelakovic
B
. Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension . Clin Ther
2000 ; 22 :1186 –233
10.
Feher
MD
Hepburn
AL
Hogarth
MB
. Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout . Rheumatology
2003 ; 42 (2 );321 –5
11.e-CPS [database on the Internet]. Ottawa (ON) : Canadian Pharmacists Association . c2004 . Available: www.pharmacists.ca/function/Subscriptions/ecps.cfm (accessed May 13, 2006)
